Filing Flows › Parabilis Medicines (PBLS) › Who owns the stock
Who owns Parabilis Medicines (PBLS) stock
80 funds reported Parabilis Medicines (PBLS) shares in their latest 13F filings, worth $2.6B in all. The largest holder is RA Capital Management, L.P. ($792M). Last quarter 72 funds added to their stakes and 0 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| RA Capital Management, L.P. | 28,933,371 | $792M | new | 2026-06-30 |
| FMR LLC | 10,292,735 | $282M | new | 2026-06-30 |
| Arch Venture Management, LLC | 6,412,780 | $176M | new | 2026-06-30 |
| venBio Partners LLC | 5,266,697 | $144M | new | 2026-06-30 |
| Alphabet | 4,919,498 | $135M | new | 2026-06-30 |
| Nextech Invest | 4,663,176 | $128M | new | 2026-06-30 |
| Cormorant Asset Management, LP | 4,615,612 | $126M | new | 2026-06-30 |
| Regeneron Pharmaceuticals | 4,166,666 | $114M | new | 2026-06-30 |
| Siren, L.L.C. | 2,992,259 | $81.9M | new | 2026-06-30 |
| Jupiter Topco LLC | 2,296,547 | $62.7M | base | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 1,920,805 | $52.6M | new | 2026-06-30 |
| Deerfield Management Company, L.P. (series C) | 1,880,704 | $51.5M | new | 2026-06-30 |
| General Catalyst Group Management, LLC | 1,600,937 | $43.8M | new | 2026-06-30 |
| General Atlantic, L.P. | 1,538,461 | $42.1M | new | 2026-06-30 |
| Soleus Capital Management, L.P. | 1,465,070 | $40.1M | new | 2026-06-30 |
Parabilis Medicines' latest quarter
Parabilis Medicines, Q2 2026: revenue $148K, net loss $52.5M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most PBLS stock?
By the latest 13F filings: RA Capital Management, L.P. ($792M); FMR LLC ($282M); Arch Venture Management, LLC ($176M); venBio Partners LLC ($144M); Alphabet ($135M).
What is the short interest in PBLS?
9,250,099 shares were sold short at the 2026-10-15 settlement, 11.97% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.